- Home
- NBH vs SOPH Comparison
NBH vs SOPH Comparison
Compare NBH & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBH | SOPH |
|---|---|---|
| Founded | 2002 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 303.6M | 330.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NBH | SOPH |
|---|---|---|
| Price | $10.10 | $4.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 85.9K | 72.8K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 4.34% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | N/A | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | N/A | $15.61 |
| P/E Ratio | $87.04 | ★ N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $8.75 | $2.58 |
| 52 Week High | $11.01 | $5.30 |
Technical Indicators
Market Signals| Indicator | NBH | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 40.56 | 49.39 |
| Support Level | $10.08 | $4.56 |
| Resistance Level | $10.24 | $4.82 |
| Average True Range (ATR) | 0.07 | 0.20 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 19.14 | 34.60 |
Price Performance
Historical ComparisonAbout NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.